We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDI.WS
9101
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$109 ﹤0.01%
3,901
+3,768
+2,833% +$240
FFAI
9102
Faraday Future Intelligent Electric
FFAI
$15.2M
0
AIRJW
9103
AirJoule Technologies Warrant
AIRJW
$105 ﹤0.01%
+73
New +$71
MACAW
9104
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$105 ﹤0.01%
+1,528
New +$119
CLNNW
9105
DELISTED
Clene Inc Warrant
CLNNW
$104 ﹤0.01%
+3,340
New +$151
IBIH icon
9106
iShares iBonds Oct 2031 Term TIPS ETF
IBIH
$64M
$103 ﹤0.01%
+4
New +$102
LGHT icon
9107
Langar Global HealthTech ETF
LGHT
$2.08M
$103 ﹤0.01%
+10
New +$104
SOAR.WS
9108
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$103 ﹤0.01%
+6,896
New +$421
AENTW icon
9109
Alliance Entertainment Holding Corp Warrants
AENTW
$3.57M
$102 ﹤0.01%
1,700
+1,668
+5,213% +$91
BNCWW
9110
CEA Industries Inc Warrant
BNCWW
$101 ﹤0.01%
6,750
+1,400
+26% +$25
XAIR icon
9111
Beyond Air
XAIR
$3.8M
-64
Closed -$31.9K
MSSS icon
9112
Monarch Select Subsector Index ETF
MSSS
$144M
$100 ﹤0.01%
+4
New +$99
BLNE
9113
Beeline Holdings
BLNE
$28.8M
$100 ﹤0.01%
10
-708
-99% -$7.32K
GLSTR
9114
DELISTED
Global Star Acquisition, Inc. Right
GLSTR
$100 ﹤0.01%
999
BMR icon
9115
Beamr Imaging
BMR
$18.8M
$99 ﹤0.01%
19
-1,528
-99% -$8.38K
RAVE icon
9116
RAVE Restaurant Group
RAVE
$44.8M
$99 ﹤0.01%
50
DSYWW
9117
Big Tree Cloud Holdings Warrant
DSYWW
$83.6K
$99 ﹤0.01%
+1,936
New +$139
NPABW
9118
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$98 ﹤0.01%
2,801
VEEAW
9119
Veea Inc Warrant
VEEAW
$97 ﹤0.01%
1,141
+1,050
+1,154% +$238
CVLY
9120
DELISTED
Codorus Valley Bancorp Inc
CVLY
$96 ﹤0.01%
4
-9,317
-100% -$206K
TLIS
9121
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$95 ﹤0.01%
11
-109
-91% -$966
REVBW icon
9122
Revelation Biosciences Warrant
REVBW
$94 ﹤0.01%
+4,715
New +$77
AMZP icon
9123
Kurv Yield Premium Strategy Amazon (AMZN) ETF
AMZP
$21.9M
$93 ﹤0.01%
3
-449
-99% -$13.8K
LQAI icon
9124
LG QRAFT AI-Powered US Large Cap Core ETF
LQAI
$2.22M
$93 ﹤0.01%
+3
New +$90
GHIXW
9125
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$92 ﹤0.01%
+1,146
New +$244

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.